Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening.

Carl A Machutta1, Christopher S Kollmann2, Kenneth E Lind2

  • 1GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, USA.

Nature Communications
|July 18, 2017
PubMed
Summary

DNA-encoded library technology (ELT) rapidly screens proteins to identify drug targets. This method effectively assesses protein ligandability, accelerating the discovery of new medicines and antibacterial leads.